# Autologous Bone Marrow Aspirate Concentrate Injection for the Treatment of Early Osteoarthritis:Baghdad 2022

> **NCT05193877** · NA · COMPLETED · sponsor: **Global Stem Cell Center, Baghdad** · enrollment: 60 (actual)

## Conditions studied

- Treatment Complication

## Interventions

- **PROCEDURE:** autologous bone marrow aspirate concentrate by centrifugation

## Key facts

- **NCT ID:** NCT05193877
- **Lead sponsor:** Global Stem Cell Center, Baghdad
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-02-08
- **Primary completion:** 2024-01-16
- **Final completion:** 2024-01-16
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2024-01-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05193877

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05193877, "Autologous Bone Marrow Aspirate Concentrate Injection for the Treatment of Early Osteoarthritis:Baghdad 2022". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05193877. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*